Drug
Arm A Pemetrexed Cisplatin
Arm A Pemetrexed Cisplatin: highest development phase Phase 2, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Arm A: Pemetrexed Cisplatin NCT00799240 | Phase 2 | Non Small Cell Lung Cancer |
Latest
No recent events.
Follow Arm A Pemetrexed Cisplatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.